JPS5519245A - Anti-malignant tumor agent composition - Google Patents

Anti-malignant tumor agent composition

Info

Publication number
JPS5519245A
JPS5519245A JP9281378A JP9281378A JPS5519245A JP S5519245 A JPS5519245 A JP S5519245A JP 9281378 A JP9281378 A JP 9281378A JP 9281378 A JP9281378 A JP 9281378A JP S5519245 A JPS5519245 A JP S5519245A
Authority
JP
Japan
Prior art keywords
fluorouracil
agent composition
malignant tumor
tumor agent
fluorouracils
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP9281378A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6223724B2 (enExample
Inventor
Setsuo Fujii
Norio Saimi
Setsuo Takeda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Priority to JP9281378A priority Critical patent/JPS5519245A/ja
Priority to GB7908960A priority patent/GB2016921B/en
Priority to CH272679A priority patent/CH639274A5/de
Priority to FR7907523A priority patent/FR2420974A1/fr
Priority to IT67629/79A priority patent/IT1119283B/it
Priority to DE2912112A priority patent/DE2912112C2/de
Publication of JPS5519245A publication Critical patent/JPS5519245A/ja
Priority to US06/552,263 priority patent/US4650801A/en
Priority to US06/932,516 priority patent/US4914105A/en
Publication of JPS6223724B2 publication Critical patent/JPS6223724B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP9281378A 1978-03-27 1978-07-28 Anti-malignant tumor agent composition Granted JPS5519245A (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
JP9281378A JPS5519245A (en) 1978-07-28 1978-07-28 Anti-malignant tumor agent composition
GB7908960A GB2016921B (en) 1978-03-27 1979-03-14 Anti cancer compositions containing uracil derivatives
CH272679A CH639274A5 (de) 1978-03-27 1979-03-23 Antikrebsmittel.
FR7907523A FR2420974A1 (fr) 1978-03-27 1979-03-26 Medicament a base de derives de l'uracile
IT67629/79A IT1119283B (it) 1978-03-27 1979-03-27 Composizione anti cancro
DE2912112A DE2912112C2 (de) 1978-03-27 1979-03-27 Antikrebs-Präparat
US06/552,263 US4650801A (en) 1978-03-27 1983-11-16 Anti-cancer compositions for delivering 5-fluorouracil
US06/932,516 US4914105A (en) 1978-03-27 1986-11-20 Anti-cancer compositions for delivering 5-fluorouracil

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9281378A JPS5519245A (en) 1978-07-28 1978-07-28 Anti-malignant tumor agent composition

Publications (2)

Publication Number Publication Date
JPS5519245A true JPS5519245A (en) 1980-02-09
JPS6223724B2 JPS6223724B2 (enExample) 1987-05-25

Family

ID=14064847

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9281378A Granted JPS5519245A (en) 1978-03-27 1978-07-28 Anti-malignant tumor agent composition

Country Status (1)

Country Link
JP (1) JPS5519245A (enExample)

Also Published As

Publication number Publication date
JPS6223724B2 (enExample) 1987-05-25

Similar Documents

Publication Publication Date Title
ATE314077T1 (de) 5-fluoro-2',3'-ungesättigte pyrimidinnucleoside
TR200101499T1 (tr) Azepinoindol türevleri, hazırlanmaları ve kullanımları.
TR200302313T4 (tr) Antivirütik pirimidin nükleosid analogları
RS20120201A3 (en) Methods and compositions for hepatitis c virus treatment
FI932870A7 (fi) 2'-deoksi-2'2'-difluori-(4-substituoitu pyrimidiini)nukleosidejä, joilla on virusvastaista ja syöpävastaista aktiivisuutta, sekä välituotteita
DE3854297D1 (de) Nucleoside und nucleotide mit antiviraler, antitumoraler, antimetastatischer sowie immunstimulierender wirkung.
AP2000001947A0 (en) Novel crystalline forms of an antiviral benzidazole compound.
ATE222765T1 (de) Verwendung von 5' substituierten nukleosiden zur hemmung von resistenzbildung bei der zytostatikabehandlung
CA2002648A1 (en) 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives
DE69500618D1 (de) Oligonukleotide mit wirkung gegen das respiratorische synzytial virus
ES2083458T3 (es) Composicion antivirica.
IE872562L (en) Nucleoside for aids treatment.
JPS55111420A (en) Antitumorigenic agent
ATE282627T1 (de) Pyrimidinnukleotid-vorläufer zur behandlung entzündlicher hepatitis
DE69324244D1 (de) Therapeutische nukleoside der 2',3'-dideoxy-3'-fluor -purin reihe
WO2001066118A8 (en) 4'-thio-l-xylo furanosyl nucleosides, precursors thereof, preparation and use thereof
EP0630249A4 (en) ANTIVIRAL 2 ', 5'-OLIGOADENYLATE DERIVATIVES WITH DOUBLE EFFECT AND THEIR USE.
JPS5519244A (en) Anti-malignant tumor agent
KR960700264A (ko) 5-알킬, 5-피리미딘을 함유하는 올리고데옥시뉴클레오티드 및 이 화합물을 함유하는 제약조성물(olgodeoxynucleotides containing 5-alkyl-, 5-(1-alkenyl)-and 5-(1-alkynyl)pyrimidines and pharmaceutical compositions containing such compounds)
IL142982A0 (en) β-L-2'-DEOXY-NUCLEOSIDES FOR THE TREATMENT OF HIV INFECTION
EP0979650A4 (en) ANTIVIRAL AGENTS
YU67103A (sh) Postupak za dobijanje (e)-5-(2-bromovinil)-2'-deoksiuridina
JPS5683420A (en) Antineoplasmic composition
JPS5677226A (en) Antitumorigenic agent
JPS5533409A (en) Carcinostatic agent